ASTRO (@ASTRO_org) header
ASTRO (@ASTRO_org) profile picture

ASTRO is the American Society for Radiation Oncology. Targeting Cancer Care. Patient education info at https://nitter.gq/t.co/j4u8EzrwzJ #radonc #medphys #radbio #DEIinRO

Arlington, VA
Joined April 2009
Photo by ASTRO (@ASTRO_org)Photo by ASTRO (@ASTRO_org)Photo by ASTRO (@ASTRO_org)Photo by ASTRO (@ASTRO_org)Photo by ASTRO (@ASTRO_org)Photo by ASTRO (@ASTRO_org)Photo by ASTRO (@ASTRO_org)Photo by ASTRO (@ASTRO_org)Photo by ASTRO (@ASTRO_org)Photo by ASTRO (@ASTRO_org)
Congratulations to Johns Hopkins University at Bethesda for achieving reaccreditation through ASTRO’s APEx - Accreditation Program for Excellence®. 🎉 ➡️Learn more & join the list of accredited facilities: bit.ly/4haNwDu @HopkinsMedicine
186
On this Veterans Day, we honor and give thanks to our veterans for their courage, dedication, and sacrifice. Thank you for your service. #VeteransDay
1
2
280
New LIVE Webinar on the ASTRO Academy: Navigating New Practice Environments: Contract, Culture and Career Success Friday, Nov. 13 | 3:00 p.m. ET This webinar will provide practical, experience-based guidance for navigating new practice environments. Moderated by @larahathout, MD, with speakers @SalmaJabbour1, MD, @MaryFengMD and @NicholasZaorsky, MD, MS. Learn more: bit.ly/4z2z5r2 @ARRO_org @S_W_R_O
3
6
653
This #LungCancerAwarenessMonth, we asked some of the talented Speed of Light - The ASTRO Foundation-funded investigators researching #LungCancer what their grant means to them. Read this quote from Tafadzwa Chaunzwa, MD, MHS, on how support from the ASTRO Foundation helped shape his research career, then read our ASTROnews Research Highlight to learn more about his work. Learn more: bit.ly/3Viiqle @TLChaunzwaMD
1
1
233
Help advance safer radiation oncology care: RO-ILS is seeking a medical dosimetrist with incident-learning experience to join the RO-HAC and review and analyze #safety data. Current #ROILS users preferred. Apply by Monday, Nov. 16: bit.ly/4AiQtZq @med_dosimetry
1
1
1
6
479
Congratulations to Johns Hopkins Bayview Medical Center for achieving reaccreditation through ASTRO’s APEx - Accreditation Program for Excellence®. 🎉 ➡️Learn more & join the list of accredited facilities: bit.ly/4haNwDu @HopkinsMedicine
1
6
410
🎥 New #RedJournal Outtake: Dr. Sheila H. Ridner on Long-Term Outcomes of Advanced Pneumatic Compression Device - Oct. 21, 2026 Watch on YouTube: bit.ly/4sQyw1Z Watch online: bit.ly/4iARnKP @IJROBP
2
4
382
Thank you Congressman Tim Kennedy (D-NY) for signing on as a co-sponsor of the Radiation Oncology Case Rate (ROCR) Act. @RepTimKennedy Rep. Kennedy is a member of the House Cancer Caucus and the 50th member of the U.S. House of Representatives to co-sponsor the ROCR Act! Learn more about the #ROCR Act here: bit.ly/4xLksIj
1
1
8
657
New Live ASTRO ROCKS Webinar: From Research Exposure to Research Independence: Building the Radiation Oncology Research Talent Pipeline Thursday, Nov. 12 | 12:30 p.m. - 1:30 p.m. ET Learn how to build and fund programs that support aspiring researchers. Register now: bit.ly/4Afw6MG @SpeedofLightFdn @ARRO_org @RadOncPDs
2
3
441
TOMORROW - New Live ASTRO Webinar: Small Fields, Big Decisions: The Evolving Role of Partial Breast Irradiation Tuesday, Nov. 10 | 2:00 p.m. ET Learn how to integrate PBI into routine practice, navigate challenging treatment decisions and individualize breast cancer care. Reserve your spot today: bit.ly/4BGKHlI
1
1
4
501
Just 2 WEEKS LEFT to apply for the 2027 Innovation Awards! The 2027 Innovation Awards will support research to better understand how to optimize radiopharmaceutical therapy (RPT, or radioligand therapy, RLT). Submit your Letter of Intent (LOI) by November 23, 2026. Learn more & apply today: bit.ly/47XB1Wm @ARRO_org @RadOncPDs @S_W_R_O @ASTRO_org
3
4
510
New in Advances in Radiation Oncology: GI radiation case volume and resident training after PROSPECT and ESOPEC. A single-center retrospective study counted 931 GI treatment starts from July 2016 through May 2026, using the first start per patient per disease site. Key findings: - Mean monthly rectal starts: 2.12 before vs 1.60 after the PROSPECT reference date. - Esophageal/gastroesophageal-junction starts: 1.57 before vs 1.35 after the ESOPEC reference date. - Across the full study window, 22% of two-month blocks had zero anal starts and 13% had zero pancreatic starts. For three-month blocks, these were 11% and 9%. Neither rectal nor esophageal decline was statistically significant. The authors report that overall GI volume was maintained as liver and pancreatic starts increased. Why this matters: overall volume does not guarantee availability of every disease site during a rotation. Important caveat: these are departmental starts, not measured resident exposure or competency. The study cannot isolate the trials' effects, and nonsignificant declines do not establish unchanged volume. Practical takeaway: use local site-specific data to identify gaps and arrange uncommon-case experiences. The more actionable risk is low-volume sites, especially anal cancer, on short rotations. doi.org/10.1016/j.adro.2026.… @ASTRO_org #RadOnc #OncTwitter
3
6
769
Join us on Saturday, Dec. 5, from 10:00 a.m. - 5:00 p.m. ET at ASTRO's 2026 Virtual Coding and Coverage Seminar: This one-day virtual seminar will address the many factors that affect this complex and ever-changing aspect of clinical practice, with the goal of making clinical coding easier to understand and apply for your practice. Along with your registration, you will receive an electronic and print version of the 2027 ASTRO Coding Resource. Learn more & register now: bit.ly/4ikuT0q
2
3
491
Happy #WeWhoCurie Day! 💜 Today, November 7, we celebrate the women shaping the future of radiation oncology and the impact they make on patient care. Join us in recognizing the women whose dedication and contributions continue to strengthen our field. #WomenInRO #WeWhoCurie @S_W_R_O
3
7
2
15
1,047
ASTRO's History Committee shares the inspiring career of Jake Haimson, DSc: Jake Haimson, DSc, shares highlights from his remarkable career in radiation physics, including his critical role in developing medical linear accelerators and his passion for philanthropy and giving back to future generations in the field. Read more about his fascinating life story: bit.ly/4ekrz3d
1
3
521
Tomorrow, November 7, we celebrate #WeWhoCurie Day! 💜 Join us in recognizing and celebrating the women who are advancing the field of #radonc through their leadership, research, innovation and dedication to patient care. Today and every day, we honor the women making a difference and inspiring the next generation of leaders in our field. #WeWhoCurie #WomenInRO @S_W_R_O
1
8
20
1,052
🚨Deadline Extended: Submit your abstract for the 2027 Multidisciplinary Radiopharmaceutical Therapy Symposium by Nov. 20 Due to popular demand, ASTRO is reopening its call for RPT abstracts! Don’t miss this additional opportunity to share your research, discoveries and clinical insights with colleagues. #MRPTS27 Submit your abstract today: bit.ly/4kkkbbZ @ABR_Radiology @SNM_MI @ACRORadOnc @ASCO @SGO_org @RSNA
1
4
3
489
Apply now for the 2027 ASTRO-ACS Clinician Scientist Development Grant (CSDG)! Investing in practicing radiation oncologists who want to conduct cancer research and care for patients. @AmericanCancer @ASTRO_org Award Amount: Up to $729,000 Award Duration: 3-5 years Applications Due Tuesday, Dec. 1, 2026. Learn more: bit.ly/4ehwsKj
2
2
498
🚨 TODAY IS THE LAST DAY TO SAVE! Don't miss your final opportunity to secure early-bird rates for the 2027 Multidisciplinary Radiopharmaceutical Therapy Symposium. Join us March 18–19, 2027, in Chantilly, VA, for #MRPTS27. Register by Friday, Nov. 6, to save: bit.ly/3Uvtv26 @ABR_Radiology @SNM_MI @ACRORadOnc @ASCO @SGO_org @RSNA
2
3
365